NYSE:LRN
K12 Inc Stock News
$70.21
-0.320 (-0.454%)
At Close: May 17, 2024
K12 (LRN) is a Great Momentum Stock: Should You Buy?
01:33pm, Thursday, 02'nd Feb 2023
Does K12 (LRN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Add These 4 Stocks With Amazing Interest Coverage Ratio
12:35pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Stride (LRN), Herc Holdings (HRI), ONEOK (OKE) and Cigna (CI) are strong enough to me
Add These 4 Stocks With Amazing Interest Coverage Ratio
09:02am, Thursday, 02'nd Feb 2023
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Stride (LRN), Herc Holdings (HRI), ONEOK (OKE) and Cigna (CI) are strong enough to me
Fox's (FOXA) Business Network Outpaces Competitor Once Again
02:52pm, Wednesday, 01'st Feb 2023 Zacks Investment Research
Fox's (FOXA) Fox Business Network leads over its competitor CNBC in business day viewers for 10 consecutive months.
Electronic Arts (EA) to Present NFL Pro Bowl 2023 on Feb 4
05:36pm, Tuesday, 31'st Jan 2023 Zacks Investment Research
Electronic Arts (EA) to host NFL Pro Bowl: Madden NFL 23 Edition on Feb 4 and feature the classic Madden Cruiser during the game for fans.
LRN or LOPE: Which Is the Better Value Stock Right Now?
04:40pm, Monday, 30'th Jan 2023 Zacks Investment Research
LRN vs. LOPE: Which Stock Is the Better Value Option?
Fox's (FOXA) Roseanne Barr:??Cancel This! to Debut on Feb 14
03:42pm, Monday, 30'th Jan 2023 Zacks Investment Research
Fox Corporation (FOXA) to debut Roseanne Barr:??Cancel This! On Feb 14 on Fox Nation, which will mark the return of Roseanne Barr to stand-up comedy after 20 years.
LRN or LOPE: Which Is the Better Value Stock Right Now?
12:48pm, Monday, 30'th Jan 2023
LRN vs. LOPE: Which Stock Is the Better Value Option?
Earnings Estimates Moving Higher for K12 (LRN): Time to Buy?
05:20pm, Friday, 27'th Jan 2023 Zacks Investment Research
K12 (LRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
K12 (LRN) Upgraded to Strong Buy: Here's What You Should Know
05:00pm, Friday, 27'th Jan 2023 Zacks Investment Research
K12 (LRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Think K12 (LRN) Could Surge 31.51%: Read This Before Placing a Bet
02:55pm, Friday, 27'th Jan 2023 Zacks Investment Research
The consensus price target hints at a 31.5% upside potential for K12 (LRN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revis
K12 (LRN) Upgraded to Strong Buy: Here's What You Should Know
01:33pm, Friday, 27'th Jan 2023
K12 (LRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Earnings Estimates Moving Higher for K12 (LRN): Time to Buy?
01:33pm, Friday, 27'th Jan 2023
K12 (LRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
06:39pm, Wednesday, 25'th Jan 2023 Benzinga
Gainers
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.
Stride's (LRN) Q2 Earnings & Revenues Beat, FY23 View Up
04:37pm, Wednesday, 25'th Jan 2023 Zacks Investment Research
Stride (LRN) reports strong fiscal Q2 revenues and earnings backed by increased enrollment and strong Adult Learning amid inflation and interest rate risks.
